170 related articles for article (PubMed ID: 16273061)
1. The business of making vaccines.
Sheridan C
Nat Biotechnol; 2005 Nov; 23(11):1359-66. PubMed ID: 16273061
[TBL] [Abstract][Full Text] [Related]
2. Building for an exit (or not).
Gunning TG
Nat Biotechnol; 2008 Sep; 26(9):971-3. PubMed ID: 18792427
[TBL] [Abstract][Full Text] [Related]
3. Profiles of four top biotech companies in India.
Suresh N; Rao ChS
Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
[No Abstract] [Full Text] [Related]
4. Bioentrepreneurship around the world.
Persidis A
Nat Biotechnol; 1998 May; 16 Suppl():3-4. PubMed ID: 9591247
[No Abstract] [Full Text] [Related]
5. Biotech firms jump on SARS bandwagon.
Basu P
Nat Biotechnol; 2003 Jul; 21(7):720. PubMed ID: 12833076
[No Abstract] [Full Text] [Related]
6. Biotech boom.
Jayaraman KS
Nature; 2005 Jul; 436(7050):480-3. PubMed ID: 16049469
[No Abstract] [Full Text] [Related]
7. Perspective: Biotech funding trends: Insights from entrepreneurs and investors.
Gruber AC
Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460
[TBL] [Abstract][Full Text] [Related]
8. Merck wipes Serono off Swiss biotech map.
Urquhart L
Nat Biotechnol; 2006 Nov; 24(11):1303. PubMed ID: 17093457
[No Abstract] [Full Text] [Related]
9. Scaling the biobusiness information mountain.
Williams G; Walsh G
Nat Biotechnol; 2005 Jan; 23(1):147-9. PubMed ID: 15706638
[No Abstract] [Full Text] [Related]
10. Showcasing bioscience in Rhode Island.
Spero D
R I Med J (2013); 2013 Feb; 96(2):15. PubMed ID: 23641419
[TBL] [Abstract][Full Text] [Related]
11. Today's biotech industry in India.
Suresh N
Biotechnol J; 2009 Mar; 4(3):291-4. PubMed ID: 19296434
[No Abstract] [Full Text] [Related]
12. China's biotech experiments.
Hepeng J
Nat Biotechnol; 2005 Dec; 23(12):1472-3. PubMed ID: 16421994
[No Abstract] [Full Text] [Related]
13. Spin-offs versus start-ups as business models in biotechnology.
Persidis A; De Rubertis F
Nat Biotechnol; 2000 May; 18(5):570-1. PubMed ID: 10802637
[No Abstract] [Full Text] [Related]
14. Early-stage returns?
Booth BL
Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
[TBL] [Abstract][Full Text] [Related]
15. Japanese firms broaden investment focus to early biotech.
Louët S; Sipp D
Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
[No Abstract] [Full Text] [Related]
16. Vaccine manufacturing: challenges and solutions.
Ulmer JB; Valley U; Rappuoli R
Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
[TBL] [Abstract][Full Text] [Related]
17. Making it in the biotech business.
Gewin V
Nature; 2005 May; 435(7038):124-5. PubMed ID: 15875029
[No Abstract] [Full Text] [Related]
18. The shrinking biotech bazaar.
Nat Biotechnol; 2019 Feb; 37(2):107. PubMed ID: 30718865
[No Abstract] [Full Text] [Related]
19. What's fueling the biotech engine?
Aggarwal S
Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
[No Abstract] [Full Text] [Related]
20. Biotech research: bringing better therapies to the people.
Heinzelmann E
Chimia (Aarau); 2010; 64(1-2):91-3. PubMed ID: 21137693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
